UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 333-280739 BELIVE HOLDINGS (Exact name of Registrant as specified in its charter) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2024 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 19 ...

Financial Performance - Sales for the three months ended March 31, 2025, were $12.64 million, a decrease of 4.4% compared to $13.22 million for the same period in 2024[15]. - Gross profit for Q1 2025 was $4.43 million, down from $4.81 million in Q1 2024, reflecting a decrease of 7.2%[15]. - Operating loss for the three months ended March 31, 2025, was $2.17 million, slightly improved from a loss of $2.18 million in Q1 2024[15]. - Net loss attributable to common shareholders for Q1 2025 was $3.50 million, compared to a net loss of $10.12 million in Q1 2024, indicating a significant reduction in losses[15]. - Basic net loss per share for Q1 2025 was $106.71, compared to $38,414.84 for Q1 2024, reflecting the impact of reverse stock splits[15]. - Total revenues for SUNation were $9,544,554 in Q1 2025, down from $9,752,970 in Q1 2024, reflecting a decrease of 2.1%[74]. - For the three months ended March 31, 2025, SUNation reported residential contract revenues of $7,896,122, a decrease of 2.9% from $8,131,708 in the same period of 2024[74]. - Commercial contract revenues increased to $1,275,888 in Q1 2025 from $997,193 in Q1 2024, representing a growth of 28%[74]. - Net loss before income taxes for Q1 2025 was $(3,481,817), compared to a net income of $1,208,813 in Q1 2024, highlighting a significant decline in profitability[152]. - Selling, general and administrative expenses for Q1 2025 totaled $6,039,298, compared to $6,629,027 in Q1 2024, indicating a reduction in overhead costs[151]. Assets and Liabilities - Total assets decreased to $44.43 million as of March 31, 2025, from $45.71 million as of December 31, 2024, representing a decline of approximately 2.8%[10]. - Total current liabilities decreased to $20.27 million as of March 31, 2025, from $27.16 million as of December 31, 2024, a reduction of approximately 25.5%[10]. - The company reported cash and cash equivalents of $1.45 million as of March 31, 2025, up from $839,268 as of December 31, 2024, an increase of approximately 72.5%[10]. - Inventories decreased to $2.51 million as of March 31, 2025, from $2.71 million as of December 31, 2024, a decline of approximately 7.2%[10]. - The balance of accumulated deficit as of March 31, 2025, was $(46,395,478), an increase from $(25,850,588) as of March 31, 2024[18]. Capital and Financing Activities - The company raised $9,473,398 from the issuance of common stock and pre-funded warrants under a registered direct offering during the three months ended March 31, 2024[22]. - The company raised approximately $20.0 million in aggregate gross proceeds from a securities offering, with $5 million from the second tranche closing on April 7, 2025[168]. - The company issued 9,825 shares of common stock under a registered direct offering, netting $8,481,892[17]. - The At the Market Offering Agreement allows the Company to sell up to $10,000,000 in common stock, with 762 shares sold for gross proceeds of $362,269 during the three months ended March 31, 2025[136]. - The Company executed a reverse stock split at a 1-for-50 ratio on October 1, 2024, reducing outstanding shares from 67,260,696 to 1,344,841[33]. - A subsequent reverse stock split at a 1-for-200 ratio was approved on April 3, 2025, reducing outstanding shares from 672,799,910 to 3,406,614[39]. - The Company increased its authorized shares to 1,000,000,000 as part of the April 2025 reverse stock split approval[36]. Debt and Interest Obligations - The loan payable to Hercules Capital, Inc. was originally $7,500,000, with an interest rate of 10%, and was due on December 31, 2024, after amendments to the Term Loan Agreement[80][81]. - The Term Loan Agreement was amended on May 31, 2023, resulting in a remaining balance of $3,375,742, with a new maturity date of June 2, 2027, and an interest rate of 10%[82]. - The Company recorded a loss on extinguishment of debt of $455,308 upon full repayment of the Term Loan on March 3, 2025[85]. - The Company recorded interest and accretion expense of $33,312 for the three months ended March 31, 2025, compared to $0 for the same period in 2024[105]. - Interest paid increased to $1,077,033 from $416,504 in the previous year[22]. Strategic Initiatives - The company’s strategy focuses on acquiring and integrating leading local and regional solar, storage, and energy services companies nationwide[26]. - The company aims to expand its operations by acquiring and integrating leading local and regional solar, storage, and energy services companies nationwide[26]. - The company plans to raise capital through public or private equity offerings, debt financings, and/or strategic alliances[166]. Accounting and Compliance - The Company is currently evaluating the impact of new accounting standards issued by the FASB, including ASU 2023-06 and ASU 2023-09, which may affect its consolidated financial statements[69][71]. - The effective income tax rate from continuing operations was (0.4%) for the three months ended March 31, 2025, differing from the federal tax rate of 21% due to state income taxes[145]. - The Company’s segment structure now includes distinct reportable segments for SUNation and Hawaii Energy Connection (HEC) due to changes in economic forecasts[148]. Market and Operational Challenges - The company received a Nasdaq delisting notice on April 11, 2025, due to not maintaining a minimum closing bid price of $1.00 per share[172]. - The company has substantial doubt about its ability to continue as a going concern, requiring additional capital resources[165].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 15, 2025 ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ ...

[PART I — FINANCIAL INFORMATION](index=2&type=section&id=PART%20I%20%E2%80%94%20FINANCIAL%20INFORMATION) [Financial Statements (Unaudited)](index=2&type=section&id=Item%201.%20Financial%20Statements%20(Unaudited)) The unaudited statements for Q1 2025 show decreased assets, a net loss of $3.3 million, and raise substantial doubt about its going concern status [Condensed Consolidated Balance Sheets](index=2&type=section&id=Condensed%20Consolidated%20Balance%20Sheets) Total assets decreased to $8.5 million and stockholders' equity fell to $1.9 million as of March 31, 2025 Condensed Consolidated Balance Sheet Highlights (in thousands) | Account | March 31, 2025 | December 31, 2024 | Change | | :--- | :--- | :--- | :--- | | **Assets** | | | | | Cash | $409 | $3,530 | ($3,121) | | Total Current Assets | $4,228 | $7,377 | ($3,149) | | Total Assets | $8,535 | $11,915 | ($3,380) | | **Liabilities & Equity** | | | | | Total Current Liabilities | $5,183 | $6,210 | ($1,027) | | Total Liabilities | $6,617 | $7,821 | ($1,204) | | Total Stockholders' Equity (Deficit) | $1,918 | $4,094 | ($2,176) | [Condensed Consolidated Statements of Operations](index=3&type=section&id=Condensed%20Consolidated%20Statements%20of%20Operations) Revenue declined 13.2% in Q1 2025, but a reduced net loss of $3.3 million was achieved due to lower operating expenses Condensed Consolidated Statements of Operations (in thousands) | Metric | Q1 2025 | Q1 2024 | Change | | :--- | :--- | :--- | :--- | | Revenue | $2,718 | $3,132 | -13.2% | | Cost of goods sold | $2,630 | $3,109 | -15.4% | | Gross profit | $88 | $23 | +282.6% | | Selling, general and administrative expenses | $3,015 | $3,884 | -22.4% | | Loss from operations | ($2,926) | ($3,861) | +24.2% | | Net Loss | ($3,324) | ($3,977) | +16.4% | | Net Loss per common share - basic and diluted | ($2.47) | ($341.14) | N/A | [Condensed Consolidated Statements of Stockholders' Equity (Deficit)](index=4&type=section&id=Condensed%20Consolidated%20Statements%20of%20Stockholders'%20Equity%20(Deficit)) Stockholders' equity decreased to $1.9 million in Q1 2025, driven by a $3.3 million net loss offset by $1.1 million in stock sale proceeds - In Q1 2025, the company issued 221,132 shares through its Equity Distribution Agreement, raising **net proceeds of $1.148 million**[17](index=17&type=chunk) - The **accumulated deficit increased by $3.324 million** during the quarter, reaching a total of $44.635 million as of March 31, 2025[17](index=17&type=chunk) [Condensed Consolidated Statements of Cash Flows](index=5&type=section&id=Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) Net cash used in operations increased significantly to $3.3 million, resulting in a quarter-end cash balance of only $0.4 million Cash Flow Summary (in thousands) | Activity | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2024 | | :--- | :--- | :--- | | Net Cash Used in Operating Activities | ($3,332) | ($1,059) | | Net Cash Used in Investing Activities | ($68) | ($55) | | Net Cash Provided by Financing Activities | $279 | $992 | | **Net Change in Cash** | **($3,121)** | **($122)** | | Cash at End of Period | $409 | $388 | [Notes to Unaudited Condensed Consolidated Financial Statements](index=6&type=section&id=Notes%20to%20Unaudited%20Condensed%20Consolidated%20Financial%20Statements) The notes detail significant risks, including customer concentration, going concern doubts, and major subsequent events like an asset purchase - The company has undergone multiple reverse stock splits, including a **1-for-20 split in April 2024** and a **1-for-25 split in March 2025**[26](index=26&type=chunk) - For the three months ended March 31, 2025, four customers accounted for approximately **92.1% of total revenue**, indicating significant customer concentration risk[38](index=38&type=chunk) - Management has concluded that **substantial doubt exists about its ability to continue as a going concern** due to recurring losses and limited cash resources[32](index=32&type=chunk)[121](index=121&type=chunk)[124](index=124&type=chunk) - Subsequent to the quarter end, the company acquired sustainable aquaculture assets from NaturalShrimp Farms Inc for **$12 million**, paid via the issuance of Series B Preferred Stock[128](index=128&type=chunk)[130](index=130&type=chunk) [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=20&type=section&id=Item%202.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses a 13.2% revenue decrease, an improved net loss, and significant liquidity challenges that threaten its going concern status [Results of Operations](index=25&type=section&id=Results%20of%20Operations) Q1 2025 revenue fell 13.2% to $2.7 million due to a strategic product exit, while reduced SG&A expenses lowered the operating loss - The **$414 thousand decrease in revenue** was primarily attributed to the company's strategic exit from the floral and lettuce categories[174](index=174&type=chunk) - **SG&A expenses decreased by $869 thousand (22.4%)** year-over-year, mainly because prior-year severance expenses were not repeated[176](index=176&type=chunk) - **Interest expense increased significantly to $440 thousand** from $117 thousand, driven by new merchant cash advance agreements[178](index=178&type=chunk) [Liquidity and Capital Resources](index=26&type=section&id=Liquidity%20and%20Capital%20Resources) The company faces significant liquidity issues with only $409 thousand in cash and has raised capital through debt and equity offerings - The company has incurred significant losses, including a **net loss of $3.3 million in Q1 2025**, and believes existing cash will only fund operations into Q3 2025[180](index=180&type=chunk)[181](index=181&type=chunk) - To meet cash needs, the company entered into **merchant cash advance agreements**, raising net proceeds of $190,000 in February and $1.435 million in April 2025[188](index=188&type=chunk)[189](index=189&type=chunk) - The company utilized its at-the-market offering to raise **net proceeds of approximately $1.3 million**[191](index=191&type=chunk) Cash Flow Activity Summary (in thousands) | Activity | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2024 | | :--- | :--- | :--- | | Cash Used for Operating Activities | $3,332 | $1,059 | | Cash Used in Investing Activities | $68 | $55 | | Cash Provided by Financing Activities | $279 | $992 | [Quantitative and Qualitative Disclosures About Market Risk](index=28&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) As a smaller reporting company, Edible Garden AG Incorporated is not required to provide the information for this item - The company is exempt from this disclosure requirement due to its status as a **smaller reporting company**[195](index=195&type=chunk) [Controls and Procedures](index=28&type=section&id=Item%204.%20Controls%20and%20Procedures) Management concluded that the company's disclosure controls and procedures were effective as of March 31, 2025 - The Chief Executive Officer and Interim Chief Financial Officer concluded that the company's **disclosure controls and procedures were effective** as of March 31, 2025[196](index=196&type=chunk) - **No material changes** in internal control over financial reporting occurred during the quarter[197](index=197&type=chunk) [PART II — OTHER INFORMATION](index=28&type=section&id=PART%20II%20%E2%80%94%20OTHER%20INFORMATION) [Legal Proceedings](index=28&type=section&id=Item%201.%20Legal%20Proceedings) The company is not currently involved in any material legal proceedings - Management does not believe there are any pending or threatened legal proceedings that would have a **material adverse effect** on the company[198](index=198&type=chunk) [Risk Factors](index=28&type=section&id=Item%201A.%20Risk%20Factors) The company faces a primary risk of delisting from Nasdaq due to non-compliance with stockholders' equity requirements - The company regained compliance with Nasdaq's minimum bid price rule but remains under a **discretionary panel monitor until April 8, 2026**[200](index=200&type=chunk)[201](index=201&type=chunk) - As of March 31, 2025, the company's **stockholders' equity was below the required $2.5 million** for continued listing on Nasdaq[202](index=202&type=chunk) - A **potential delisting from Nasdaq** could severely reduce stock liquidity, hinder capital raising, and damage customer confidence[205](index=205&type=chunk) [Exhibits](index=29&type=section&id=Item%206.%20Exhibits) This section lists key agreements and officer certifications filed as exhibits with the Form 10-Q - Key exhibits filed include the **Equity Distribution Agreement** and the **Standard Merchant Cash Advance Agreement** with Arin Funding[204](index=204&type=chunk) [Signatures](index=30&type=section&id=Signatures) The report was duly signed by the Chief Executive Officer and Interim Chief Financial Officer on May 15, 2025

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 001-41097 Cardio Diagnostics Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 87-0925574 (St ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to _____________ Commission File Number: 001-41612 ASSET ENTITIES INC. (Exact name of registrant as specified in its charter) Nevada 88-1293236 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2025 1847 Holdings LLC | (Exact name of registrant as specified in its charter) | | | | --- | --- | --- | | Delaware | 001-41368 | 38-3922937 | | (State or other jurisdiction | (Commission File Number) | (IRS Employer | | of incorporation) | | Identification No.) | | 260 Madison Avenue, ...

Exhibit 99.1 Lakeside Announces Fiscal 2025 Third Quarter and Nine-Month Results ITASCA, IL, May 15, 2025 (GLOBE NEWSWIRE) -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market operating through two specialized subsidiaries—American Bear Logistics and Hupan Pharmaceutical (Hubei) Co., Ltd., today announced financial results for its fiscal 2025 third quarter and nine months ended March 3 ...

Financial Results and Updates - TuHURA Biosciences reported financial results for Q1 2025, with a focus on corporate updates[7]. - TuHURA's financial condition and operational results are detailed in the press release dated May 15, 2025[7]. - The company has not undertaken any obligation to update forward-looking statements unless required by securities laws[14]. Acquisition and Merger - The company is in the process of acquiring Kineta, Inc., with a registration statement filed on February 7, 2025[8]. - The merger with Kineta is expected to enhance TuHURA's capabilities in tumor microenvironment modulators[13]. - TuHURA is actively seeking additional capital to support the Kineta merger and its ongoing development programs[13]. - The company emphasizes the importance of reading the Joint Proxy Statement/Prospectus for detailed information regarding the merger[9]. Product Development - TuHURA's product candidate IFx-Hu2.0 is anticipated to enter Phase 3 trials, indicating progress in its development pipeline[13]. - The anticipated regulatory pathway and timing for TuHURA's development programs are outlined as part of their forward-looking statements[13]. Stock Information - TuHURA's stock is traded on The Nasdaq Capital Market under the symbol HURA[5].